Relationship Between Laboratory-Measured HbA1c and Continuous Glucose Monitoring-Derived Glucose Management Indicator in Adults With Cystic Fibrosis-Related Diabetes.

Abstract

Cystic Fibrosis (CF) diabetes is characterised by progressive destruction of beta-cells, dysfunctional and inadequate insulin secretion, and fluctuating insulin resistance. Introduction of cystic fibrosis transmembrane conductance regulator (CFTR) modulators has led to people with CF living longer and healthier lives. Non-pulmonary complications, including CF diabetes, have become increasingly common and burdensome.